ATRX and metastatic neoplasm: To further investigate biomarkers related to the risk of MeNET metastasis and recurrence, ATRX, c-Myc, ANO1, and p53 were detected by immunohistochemistry in this case, among which ATRX was observed in both primary and metastatic tumor tissues.